Mutational load (ML) and T-cell-inflamed microenvironment as predictors of response to pembrolizumab.

被引:10
作者
Cristescu, Razvan
Mogg, Robin
Ayers, Mark
Albright, Andrew
Murphy, Erin
Yearley, Jennifer
Sher, Xinwei
Liu, Xiaoqiao
Nebozhyn, Michael
Lunceford, Jared K.
Joe, Andrew K.
Cheng, Jonathan
Plimack, Elizabeth R.
Ott, Patrick Alexander
Seiwert, Tanguy Y.
McClanahan, Terrill K.
Loboda, Andrey
Kaufman, David Ross
机构
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
10.1200/JCO.2017.35.7_suppl.1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1
引用
收藏
页数:1
相关论文
empty
未找到相关数据